Peter Ruane
机构：Ruane Medical · ORCID：0000-0002-7170-9928
发表论文 138 篇 · 总被引 14028 次 · h-index 51
代表论文
- Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection (2022 · New England Journal of Medicine · 被引 311)
- Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons (2024 · New England Journal of Medicine · 被引 256)
- Lenacapavir administered every 26 weeks or daily in combination with oral daily antiretroviral therapy for initial treatment of HIV: a randomised, open-label, active-controlled, phase 2 trial (2022 · The Lancet HIV · 被引 106)
- A randomized, double-blind, placebo-controlled phase IIa trial of efruxifermin for patients with compensated NASH cirrhosis (2022 · JHEP Reports · 被引 103)
- Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial (2023 · The Lancet HIV · 被引 71)
- Safety of teropavimab and zinlirvimab with lenacapavir once every 6 months for HIV treatment: a phase 1b, randomised, proof-of-concept study (2024 · The Lancet HIV · 被引 47)